Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia–reperfusion-induced gastric lesions

This publication has 30 references indexed in Scilit:

• NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
  Published by Elsevier ,2002
• Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats
  British Journal of Pharmacology, 1998
• Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: Role in resistance to damage
  Gastroenterology, 1997
• Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
  Science, 1997
• Role of β-Adrenoceptors in Gastric Mucosal Integrity and Gastroprotection Induced by Epidermal Growth Factor
  Digestion, 1997
• A new gastric ulcer model induced by ischemia-reperfusion in the rat: Role of leukocytes on ulceration in rat stomach
  Life Sciences, 1996
• CYCLOOXYGENASE-2 INHIBITORS: A New Class of Anti-Inflammatory Agents That Spare the Gastrointestinal Tract
  Gastroenterology Clinics of North America, 1996
• Cloning and Expression of Rat Prostaglandin Endoperoxide Synthase (Cyclooxygenase)-2 cDNA
  Biochemical and Biophysical Research Communications, 1993
• Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying
  Life Sciences, 1991
• Cytoprotective and Ulcer Healing Properties of Prostaglandin E2, Colloidal Bismuth and Sucralfate in Rats
  Digestion, 1987